BIOMAT Database Logo BIOMAT Database Logo

Clearance of cervical human papillomavirus infection by treatment for cervical dysplasia. 1997

L J Bollen, and S P Tjong-A-Hung, and J van der Velden, and B W Mol, and K Boer, and F J ten Kate, and O P Bleker, and J ter Schegget
Department of Virology, University of Amsterdam, Academic Medical Center, The Netherlands.

OBJECTIVE The aim of this study was to investigate the prevalence of human papillomavirus (HPV) after treatment for cervical dysplasia. METHODS The presence of HPV was investigated in cervical scrapes of 91 patients, before and after treatment, using consensus primers in the polymerase chain reaction. RESULTS Before treatment for cervical dysplasia, 89 of 91 patients (98%) were HPV-positive compared with 28 of 91 patients (31%) after treatment. The HPV type present before treatment was found in the scrapes of only 9 of 89 patients (10%). Detection of HPV after treatment was associated with human immunodeficiency virus infection and incomplete conization. CONCLUSIONS The HPV type present before treatment was frequently cleared by treatment for cervical dysplasia.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009426 Netherlands Country located in EUROPE. It is bordered by the NORTH SEA, BELGIUM, and GERMANY. Constituent areas are Aruba, Curacao, and Sint Maarten, formerly included in the NETHERLANDS ANTILLES. Holland,Kingdom of the Netherlands
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002578 Uterine Cervical Dysplasia Abnormal development of immature squamous EPITHELIAL CELLS of the UTERINE CERVIX, a term used to describe premalignant cytological changes in the cervical EPITHELIUM. These atypical cells do not penetrate the epithelial BASEMENT MEMBRANE. Cervical Dysplasia,Cervical Intraepithelial Neoplasia,Cervix Dysplasia,Dysplasia of Cervix Uteri,Neoplasia, Cervical Intraepithelial,Cervical Intraepithelial Neoplasia, Grade III,Cervical Intraepithelial Neoplasms,Intraepithelial Neoplasia, Cervical,Cervical Dysplasia, Uterine,Cervical Dysplasias,Cervical Intraepithelial Neoplasm,Cervix Uteri Dysplasia,Cervix Uteri Dysplasias,Dysplasia, Cervical,Dysplasia, Cervix,Dysplasia, Uterine Cervical,Intraepithelial Neoplasm, Cervical,Intraepithelial Neoplasms, Cervical,Neoplasm, Cervical Intraepithelial,Neoplasms, Cervical Intraepithelial
D002583 Uterine Cervical Neoplasms Tumors or cancer of the UTERINE CERVIX. Cancer of Cervix,Cancer of the Cervix,Cancer of the Uterine Cervix,Cervical Cancer,Cervical Neoplasms,Cervix Cancer,Cervix Neoplasms,Neoplasms, Cervical,Neoplasms, Cervix,Uterine Cervical Cancer,Cancer, Cervical,Cancer, Cervix,Cancer, Uterine Cervical,Cervical Cancer, Uterine,Cervical Cancers,Cervical Neoplasm,Cervical Neoplasm, Uterine,Cervix Neoplasm,Neoplasm, Cervix,Neoplasm, Uterine Cervical,Uterine Cervical Cancers,Uterine Cervical Neoplasm
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

L J Bollen, and S P Tjong-A-Hung, and J van der Velden, and B W Mol, and K Boer, and F J ten Kate, and O P Bleker, and J ter Schegget
Clearance of human papillomavirus in women treated for cervical dysplasia.
July 2011, Obstetrics and gynecology,
L J Bollen, and S P Tjong-A-Hung, and J van der Velden, and B W Mol, and K Boer, and F J ten Kate, and O P Bleker, and J ter Schegget
Clearance of human papillomavirus in women treated for cervical dysplasia.
January 2011, Obstetrics and gynecology,
L J Bollen, and S P Tjong-A-Hung, and J van der Velden, and B W Mol, and K Boer, and F J ten Kate, and O P Bleker, and J ter Schegget
The clearance of oral high-risk human papillomavirus infection is impaired by long-term persistence of cervical human papillomavirus infection.
November 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,
L J Bollen, and S P Tjong-A-Hung, and J van der Velden, and B W Mol, and K Boer, and F J ten Kate, and O P Bleker, and J ter Schegget
Cervical dysplasia and human papillomavirus.
April 1989, American journal of obstetrics and gynecology,
L J Bollen, and S P Tjong-A-Hung, and J van der Velden, and B W Mol, and K Boer, and F J ten Kate, and O P Bleker, and J ter Schegget
Clearance of cervical human papillomavirus infections.
March 2003, International journal of cancer,
L J Bollen, and S P Tjong-A-Hung, and J van der Velden, and B W Mol, and K Boer, and F J ten Kate, and O P Bleker, and J ter Schegget
Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia.
September 1995, Journal of the National Cancer Institute,
L J Bollen, and S P Tjong-A-Hung, and J van der Velden, and B W Mol, and K Boer, and F J ten Kate, and O P Bleker, and J ter Schegget
Human papillomavirus type-specific persistence and recurrence after treatment for cervical dysplasia.
April 2014, Journal of medical virology,
L J Bollen, and S P Tjong-A-Hung, and J van der Velden, and B W Mol, and K Boer, and F J ten Kate, and O P Bleker, and J ter Schegget
Rate of human papillomavirus clearance after treatment of cervical intraepithelial neoplasia.
November 2002, Obstetrics and gynecology,
L J Bollen, and S P Tjong-A-Hung, and J van der Velden, and B W Mol, and K Boer, and F J ten Kate, and O P Bleker, and J ter Schegget
The Role of Micronutrients in Human Papillomavirus Infection, Cervical Dysplasia, and Neoplasm.
June 2023, Healthcare (Basel, Switzerland),
L J Bollen, and S P Tjong-A-Hung, and J van der Velden, and B W Mol, and K Boer, and F J ten Kate, and O P Bleker, and J ter Schegget
The role of human papillomavirus testing after treatment for high-grade cervical dysplasia.
January 2016, Journal of gynecologic oncology,
Copied contents to your clipboard!